China Genetic Testing Market Share, Price Trends, Growth

According to IMARC Group’s latest report, titled “China Genetic Testing Market: Industry Trends, Share, Size, Growth, Opportunities and Forecast 2022-2027”, the China genetic testing market size reached 3.1 billion. by 2021. IMARC Group expects the market to reach US$8.0 billion by 2027, growing at a growth rate (CAGR) of 17% over the period 2022-2027.

Genetic testing identifies changes that occur in an individual’s genes, proteins or chromosomes. They help determine a person’s chances of passing on a genetic disease to the next generation as well as their susceptibility to a suspected genetic disease. The genetic testing market in China has witnessed rapid development since the establishment of the first genomics company in 1999. The demand for genetic testing services in the country is driven by factors such as an aging population, expanding middle class and investments in the health sector. The industry has also attracted international investors due to the growing demand for non-invasive prenatal testing and growing research in the areas of reproductive health and oncology.

We regularly monitor the direct effect of COVID-19 on the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.

Request a sample PDF of this report:

Genetic testing market trends in China:

In order to expand its national biotechnology sector, the Chinese government has taken steps towards the development of genetic sciences. It has identified genomics as a strategic area for the social and economic development of the country in its 14th five-year plan. The government also plans to document the genetic makeup of people from nine different minority groups, with the aim of decoding the hereditary information contained in their genes. Apart from this, the direct-to-consumer DNA testing market has also witnessed massive growth driven by the rising priority of personal health and wellness among consumers. This trend has further been supported by advances in technology that have reduced the cost of DNA sequencing services. However, there is a lack of educational programs specifically designed to train medical genetics professionals in China.

Competitive Analysis and Segmentation of Genetic Testing in China 2022-2027:

Competitive landscape with key players:

Berry Genomics Co. ltd.
Daan Gene Co. Ltd
Annoroad Gene Technology Co.Ltd.
WuXi PharmaTech

Key Market Segmentation:

Breakdown by type of test:

Prenatal test
carrier test
Newborn test
Predictive/presymptomatic test
Diagnostic tests

Breakdown by disease:

Down syndrome

Breakdown by technology:


Breakdown by service provider:

Hospital laboratories
Independent Laboratories
Specialized clinics

Breakage per test sample:


Ask the analyst for a customization and explore the full report with table of contents and list of figures:

Main highlights of the report:

Market Performance (2016-2021)
Market Outlook (2022-2027)
Porter’s Five Forces Analysis
Market drivers and success factors
SWOT analysis
Value chain
Complete mapping of the competitive landscape

Contact us:

30 N Gould St Ste R
Sheridan, Wyoming 82801 USA – Wyoming
Email: [email protected]
Such. :(D) +91 120 433 0800
Americas: – +1 631 791 1145 | Africa and Europe: – +44-702-409-7331 | Asia: +91-120-433-0800

About Us:

The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.

IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.

This press release was published on openPR.

Comments are closed.